A peptide encoded in the mitochondrial genome
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene — not in the nucleus, where the overwhelming majority of cellular proteins originate. This makes it a mitochondrial-derived peptide (MDP), a small class of molecules that reframed the mitochondrion as a signaling organelle rather than only a site of energy production. The origin is not trivia; it is the premise of the mechanism, because it positions MOTS-c as a message the mitochondria can send about their own state.
AMPK: the energy-sensing pathway
The central studied property is activation of AMPK, the AMP-activated protein kinase. AMPK functions as the cell’s fuel gauge: when the ratio of AMP to ATP rises — meaning energy is being consumed faster than it is produced — AMPK activates and shifts the cell toward catabolic, energy-generating processes and away from energy-consuming ones. A mitochondrially encoded peptide that engages this pathway constitutes a direct link between mitochondrial status and whole-cell metabolic behavior.
The folate–AICAR–purine biosynthesis axis
Research connects MOTS-c to the folate cycle and de novo purine biosynthesis, specifically the accumulation of AICAR — an intermediate in that pathway and a known endogenous AMPK activator. The proposed sequence is indirect: influence on the folate-dependent purine pathway alters AICAR levels, and AICAR in turn activates AMPK. This is worth stating precisely, because "MOTS-c activates AMPK" is often repeated as though the interaction were direct, when the literature describes a metabolic-intermediate route.
Nuclear translocation under metabolic stress
The second mechanistic observation is spatial. Under conditions of metabolic stress, studies report translocation of MOTS-c to the nucleus, where it is associated with stress-adaptive gene expression. A peptide that originates in the mitochondrion and relocates to the nucleus under stress is, in effect, retrograde signaling — the organelle communicating its condition to the genome. This is the mechanistic feature that distinguishes MOTS-c from conventional metabolic research compounds.
What the mechanism does not establish
AMPK activation and nuclear translocation are observations from cell-culture and animal metabolic models. They describe a signaling architecture, not a demonstrated effect on metabolism, body composition, or health in any other context. MOTS-c is not approved for human or veterinary use, and no dosing or therapeutic guidance exists or is provided here.
Reference data
| Compound | MOTS-c · Mitochondrial ORF of the 12S rRNA type-c |
| Molecular weight | 2,174.4 g/mol |
| Sequence / form | Mitochondrial-derived 16-aa peptide |
| Research class | Mitochondrial |
| Verification | Independent five-point panel (MZ Biolabs, Arizona) — lot-specific COA |
Where it appears in research
- AMPK pathway and cellular energy-sensing assays
- Mitochondrial biogenesis and metabolic-resilience models
- Insulin-sensitivity and glucose-metabolism research
- Exercise-metabolism and metabolic-stress studies
Ethos Bio supplies MOTS-c strictly as a research reagent. Every lot is independently verified by MZ Biolabs, a third-party analytical laboratory in Arizona, on a five-point panel — RP-HPLC purity, HPLC-MS identity, endotoxin (LAL), heavy metals, and sterility — with a lot-specific Certificate of Analysis shipped alongside the vial.
MOTS-c reference materials
Read the full monograph for sequence, specifications, and research context, or review the lot-specific certificate of analysis.
Frequently asked questions
What is the mechanism of action of MOTS-c?
In research models MOTS-c is associated with activation of the AMPK energy-sensing pathway, linked to the folate–AICAR–de novo purine biosynthesis axis, and with nuclear translocation under metabolic stress where it influences stress-adaptive gene expression. Findings are from cell-culture and animal models.
Why is MOTS-c called a mitochondrial-derived peptide?
Because it is encoded within the mitochondrial 12S rRNA gene rather than in nuclear DNA. That places it in a small class of mitochondrial-derived peptides studied as signals from the mitochondrion to the rest of the cell.
Does MOTS-c activate AMPK directly?
The literature describes an indirect route. MOTS-c is associated with the folate cycle and de novo purine biosynthesis, affecting levels of AICAR — an endogenous AMPK activator — which in turn activates AMPK. Describing the interaction as direct overstates the published mechanism.
Is MOTS-c approved for human use?
No. MOTS-c is sold strictly for laboratory research use only. It is not a drug or supplement and is not approved for human or veterinary use or consumption.